| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 113.85B | 104.02B | 97.61B | 88.78B | 81.48B |
| Gross Profit | 71.45B | 63.79B | 58.00B | 52.72B | 49.86B |
| EBITDA | 65.58B | 59.49B | 54.18B | 49.07B | 47.20B |
| Net Income | 41.36B | 37.64B | 32.91B | 30.01B | 29.75B |
Balance Sheet | |||||
| Total Assets | 270.13B | 268.34B | 272.64B | 243.62B | 230.76B |
| Cash, Cash Equivalents and Short-Term Investments | 110.43B | 116.22B | 112.01B | 95.69B | 82.38B |
| Total Debt | 2.10B | 2.25B | 2.66B | 2.42B | 2.83B |
| Total Liabilities | 59.16B | 60.98B | 73.61B | 49.47B | 48.28B |
| Stockholders Equity | 207.52B | 204.20B | 196.00B | 191.46B | 180.34B |
Cash Flow | |||||
| Free Cash Flow | 34.56B | 35.39B | 45.05B | 32.81B | 35.50B |
| Operating Cash Flow | 43.91B | 38.16B | 47.15B | 36.91B | 36.63B |
| Investing Cash Flow | -21.27B | -6.00B | -2.65B | -9.07B | -1.34B |
| Financing Cash Flow | -38.43B | -29.95B | -28.19B | -17.12B | -24.68B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥817.70B | 19.74 | 19.13% | 2.64% | 9.45% | 12.93% | |
64 Neutral | ¥132.84B | 11.41 | ― | 2.82% | 13.31% | -11.40% | |
63 Neutral | ¥29.44B | 12.39 | ― | 4.79% | -8.90% | -31.83% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
56 Neutral | ¥52.40B | 11.80 | ― | 4.49% | 10.55% | -5.43% | |
53 Neutral | ¥277.68B | 17.73 | ― | 1.24% | 19.04% | 108.13% | |
49 Neutral | ¥3.60B | 21.74 | ― | 1.08% | -0.94% | ― |